Torrent Pharmaceuticals enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
1,54,236————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
2,9641,983685976664
0.09,1960.0—0.0
14,79814,7983,0263,9385,297
1,66,070————
11,83412,8152,3412,9624,633
₹4,906.64————
33,17132,38310,61710,79411,495
44.6%45.7%28.5%36.5%46.1%
0.09×————
9.54×————
28.76×————
43.05×————
70.79×————
Reference items — trailing FY values
17,40013,98011,51610,7289,620
5,7744,5593,7213,3682,842
3,8583,4402,9262,5602,135
—3,0232,5853,2662,368
2,3462,3461,9742,8331,794
—2,2371,8992,7231,695
—677611433574
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

TORNTPHARM₹4,557.00

Torrent Pharmaceuticals Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMAJBCHEPHARMMANKINDZYDUSLIFEDIVISLABMAXHEALTHDRREDDYCIPLAMcap ₹1.54L Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————1,54,236.2
- Cash, Equiv & ST Investments664.0976.0685.01,983.02,964.0
+ Minority Interest0.0—0.09,196.00.0
+ Total Debt5,297.03,938.03,026.014,798.014,798.0
Enterprise Value————1,66,070.2
Net Debt (memo)4,633.02,962.02,341.012,815.011,834.0
EV per Share————4,906.64
Total Capital11,495.010,794.010,617.032,383.033,171.0
Total Debt/Total Capital46.0836.4828.5045.7044.61
Total Debt/EV————0.09
EV/Sales————9.54
EV/EBITDA————28.76
EV/EBIT————43.05
EV/Free Cash Flow————70.79
Reference Items — Trailing FY Values
Sales9,620.010,728.011,516.013,980.017,400.0
EBITDA2,842.03,368.03,721.04,559.05,774.0
EBIT2,135.02,560.02,926.03,440.03,858.0
Operating Cash Flow2,368.03,266.02,585.03,023.0—
Free Cash Flow1,794.02,833.01,974.02,346.02,346.0
FCFF (free cash flow to the firm)1,695.22,723.21,899.32,236.9—
Capital Expenditure574.0433.0611.0677.0—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.